Suppr超能文献

相似文献

1
Identification of potential SARS-CoV-2 M inhibitors integrating molecular docking and water thermodynamics.
J Biomol Struct Dyn. 2022 Jul;40(11):5079-5089. doi: 10.1080/07391102.2020.1867642. Epub 2021 Jan 8.
3
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
Virus Res. 2020 Oct 15;288:198102. doi: 10.1016/j.virusres.2020.198102. Epub 2020 Jul 24.
5
Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study.
J Biomol Struct Dyn. 2024 Aug;42(13):6892-6903. doi: 10.1080/07391102.2023.2236714. Epub 2023 Jul 17.
7
Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
J Biomol Struct Dyn. 2022 May;40(8):3777-3788. doi: 10.1080/07391102.2020.1850359. Epub 2020 Nov 30.
9
Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
J Biomol Struct Dyn. 2022 Sep;40(14):6556-6568. doi: 10.1080/07391102.2021.1897680. Epub 2021 Mar 8.

本文引用的文献

1
First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients.
Medicine (Baltimore). 2020 Nov 25;99(48):e23357. doi: 10.1097/MD.0000000000023357.
2
Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease.
Sci Adv. 2020 Sep 11;6(37). doi: 10.1126/sciadv.abd0345. Print 2020 Sep.
3
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.
Nat Commun. 2020 Sep 4;11(1):4417. doi: 10.1038/s41467-020-18233-x.
4
Reply to: "Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19".
Open Forum Infect Dis. 2020 Jul 29;7(8):ofaa321. doi: 10.1093/ofid/ofaa321. eCollection 2020 Aug.
6
Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
J Mol Graph Model. 2020 Nov;100:107710. doi: 10.1016/j.jmgm.2020.107710. Epub 2020 Aug 11.
7
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
Viruses. 2020 Aug 7;12(8):861. doi: 10.3390/v12080861.
9
The SARS-CoV-2 main protease as drug target.
Bioorg Med Chem Lett. 2020 Sep 1;30(17):127377. doi: 10.1016/j.bmcl.2020.127377. Epub 2020 Jul 2.
10
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Nature. 2020 Aug;584(7821):450-456. doi: 10.1038/s41586-020-2571-7. Epub 2020 Jul 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验